Viewing Study NCT00062205


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2025-12-26 @ 2:09 AM
Study NCT ID: NCT00062205
Status: COMPLETED
Last Update Posted: 2010-02-09
First Post: 2003-06-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor
Sponsor: City of Hope Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module